Change in index, by region
One dot per nation. The bar marks each region’s mean. Further left is a larger fall.
Does capability protect?
Each nation’s baseline index against its fall. Stronger nations absorb more of the shock, so they sit higher; so do nations with low exposure.
Where the load lands
Mean change in each capability domain across all nations.
What policy is worth
The 20 hardest-hit nations under three policy responses. The distance from circle to square is what current buffers absorb; from square to diamond is what best practice would add.
All 197 nations
Rank shift is the change in the nation’s place among all nations once every index is stressed: up means it held up better than its neighbours. The weakest point is the capability left lowest among those the scenario singles out.
| Weakest point | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Monaco | Europe | High 1.00 | 5.91 | 4.91 | −1.01 | −17.0 | ▼ 6 | 21 · 4d | 30% | Biotechnology & Health Technologies 0 · Inception |
| Libya | Africa | High 0.78 | 3.01 | 1.99 | −1.01 | −33.7 | ▼ 8 | 28 | 12% | Biotechnology & Health Technologies 0 · Inception |
| San Marino | Europe | High 0.97 | 5.03 | 4.05 | −0.98 | −19.4 | ▼ 5 | 21 · 3d | 24% | Biotechnology & Health Technologies 0 · Inception |
| Venezuela | Latin America and Caribbean | High 0.76 | 4.55 | 3.58 | −0.98 | −21.4 | ▼ 4 | 30 · 3d | 17% | Fiscal Capacity & Public Finance 0.9 · Inception |
| Nauru | Indo-Pacific | High 0.82 | 1.96 | 1.01 | −0.96 | −48.6 | ▼ 3 | 13 · 2d | 10% | Biotechnology & Health Technologies 0 · Inception |
| North Korea | Indo-Pacific | High 0.77 | 4.26 | 3.32 | −0.95 | −22.2 | ▼ 4 | 21 · 1d | 19% | Fiscal Capacity & Public Finance 0 · Inception |
| Djibouti | Africa | High 0.78 | 3.20 | 2.25 | −0.95 | −29.7 | ▼ 5 | 27 · 4d | 13% | Biotechnology & Health Technologies 0 · Inception |
| Malta | Europe | High 0.97 | 8.89 | 7.95 | −0.94 | −10.6 | ▼ 1 | 27 · 4d | 37% | Biotechnology & Health Technologies 2.6 · Inception |
| Kosovo | Europe | High 0.79 | 4.70 | 3.77 | −0.93 | −19.8 | ▼ 4 | 19 · 1d | 20% | Biotechnology & Health Technologies 0 · Inception |
| Lebanon | Gulf and Middle East | High 0.75 | 4.66 | 3.73 | −0.93 | −19.9 | ▼ 5 | 26 · 2d | 19% | Fiscal Capacity & Public Finance 1.2 · Inception |
| Palau | Indo-Pacific | High 0.78 | 2.84 | 1.92 | −0.92 | −32.4 | ▼ 2 | 20 · 2d | 13% | Biotechnology & Health Technologies 0 · Inception |
| Marshall Islands | Indo-Pacific | High 0.77 | 2.48 | 1.56 | −0.92 | −37.0 | ▼ 4 | 14 · 2d | 12% | Biotechnology & Health Technologies 0 · Inception |
| Montenegro | Europe | High 0.82 | 6.35 | 5.44 | −0.91 | −14.4 | ▼ 3 | 15 · 5d | 27% | Biotechnology & Health Technologies 0.2 · Inception |
| Andorra | Europe | High 0.91 | 5.15 | 4.25 | −0.91 | −17.6 | ▼ 4 | 24 · 2d | 26% | Biotechnology & Health Technologies 0 · Inception |
| Gabon | Africa | High 0.75 | 3.94 | 3.02 | −0.91 | −23.2 | ▼ 9 | 17 · 2d | 16% | Biotechnology & Health Technologies 0 · Inception |
| North Macedonia | Europe | High 0.80 | 6.61 | 5.72 | −0.89 | −13.4 | ▼ 1 | 21 · 3d | 27% | Biotechnology & Health Technologies 0.7 · Inception |
| Bosnia & Herzegovina | Europe | High 0.75 | 5.80 | 4.92 | −0.88 | −15.2 | ▼ 3 | 16 · 4d | 23% | Biotechnology & Health Technologies 0.3 · Inception |
| Brunei | Indo-Pacific | High 0.80 | 5.60 | 4.72 | −0.88 | −15.8 | ▼ 3 | 20 · 3d | 25% | Biotechnology & Health Technologies 0 · Inception |
| Suriname | Latin America and Caribbean | High 0.75 | 4.04 | 3.16 | −0.88 | −21.7 | ▼ 7 | 21 · 3d | 17% | Biotechnology & Health Technologies 0 · Inception |
| Dominica | Latin America and Caribbean | High 0.76 | 3.87 | 3.01 | −0.87 | −22.3 | ▼ 6 | 17 · 3d | 18% | Biotechnology & Health Technologies 0 · Inception |
| Bulgaria | Europe | High 0.86 | 8.95 | 8.09 | −0.86 | −9.6 | ▼ 1 | 23 · 3d | 35% | Biotechnology & Health Technologies 4.9 · Nascent |
| El Salvador | Latin America and Caribbean | High 0.74 | 5.68 | 4.81 | −0.86 | −15.2 | ▼ 4 | 23 · 4d | 24% | Biotechnology & Health Technologies 0.3 · Inception |
| Tuvalu | Indo-Pacific | High 0.73 | 2.12 | 1.26 | −0.86 | −40.5 | ▼ 3 | 10 · 1d | 11% | Biotechnology & Health Technologies 0 · Inception |
| Mongolia | Indo-Pacific | High 0.74 | 5.73 | 4.89 | −0.85 | −14.7 | ▼ 4 | 12 · 2d | 25% | Biotechnology & Health Technologies 0.5 · Inception |
| Seychelles | Africa | High 0.79 | 5.27 | 4.42 | −0.85 | −16.1 | 0 | 22 · 2d | 24% | Biotechnology & Health Technologies 0 · Inception |
| Bahamas | Latin America and Caribbean | High 0.77 | 5.16 | 4.32 | −0.85 | −16.4 | ▼ 3 | 21 · 1d | 22% | Biotechnology & Health Technologies 0 · Inception |
| Cyprus | Europe | High 0.83 | 8.51 | 7.67 | −0.84 | −9.9 | 0 | 26 · 1d | 34% | Biotechnology & Health Technologies 2.2 · Inception |
| Fiji | Indo-Pacific | High 0.72 | 5.16 | 4.33 | −0.83 | −16.0 | ▼ 1 | 21 · 2d | 21% | Biotechnology & Health Technologies 0 · Inception |
| Nicaragua | Latin America and Caribbean | High 0.69 | 4.37 | 3.53 | −0.83 | −19.1 | ▼ 3 | 22 · 3d | 19% | Biotechnology & Health Technologies 0 · Inception |
| Albania | Europe | High 0.73 | 6.13 | 5.31 | −0.82 | −13.4 | ▼ 3 | 15 · 5d | 25% | Biotechnology & Health Technologies 0 · Inception |
| Saint Vincent & Grenadines | Latin America and Caribbean | High 0.72 | 3.76 | 2.94 | −0.82 | −21.9 | ▼ 4 | 17 · 3d | 17% | Biotechnology & Health Technologies 0 · Inception |
| Belarus | Russia and Eurasia | High 0.74 | 6.90 | 6.10 | −0.81 | −11.7 | ▼ 2 | 25 · 3d | 30% | Biotechnology & Health Technologies 3.6 · Nascent |
| Grenada | Latin America and Caribbean | High 0.71 | 4.04 | 3.23 | −0.81 | −20.0 | ▼ 3 | 18 · 2d | 18% | Biotechnology & Health Technologies 0 · Inception |
| Congo | Africa | High 0.65 | 3.19 | 2.38 | −0.81 | −25.4 | ▼ 1 | 25 · 5d | 12% | Biotechnology & Health Technologies 0 · Inception |
| Kiribati | Indo-Pacific | High 0.68 | 2.20 | 1.39 | −0.81 | −36.9 | ▼ 1 | 16 · 1d | 11% | Biotechnology & Health Technologies 0 · Inception |
| Luxembourg | Europe | High 0.93 | 10.79 | 9.99 | −0.80 | −7.4 | ▼ 3 | 20 · 4d | 44% | Biotechnology & Health Technologies 3.4 · Nascent |
| Greece | Europe | High 0.86 | 10.61 | 9.81 | −0.80 | −7.6 | ▼ 1 | 22 | 40% | Biotechnology & Health Technologies 5.8 · Nascent |
| Latvia | Europe | High 0.86 | 9.89 | 9.09 | −0.80 | −8.1 | 0 | 31 · 3d | 40% | Biotechnology & Health Technologies 4.1 · Nascent |
| Paraguay | Latin America and Caribbean | High 0.70 | 5.79 | 4.98 | −0.80 | −13.9 | ▼ 1 | 20 · 2d | 25% | Biotechnology & Health Technologies 0.2 · Inception |
| Cabo Verde | Africa | High 0.71 | 4.72 | 3.92 | −0.80 | −17.0 | ▼ 1 | 21 · 3d | 20% | Biotechnology & Health Technologies 0 · Inception |
| Mauritania | Africa | High 0.64 | 3.58 | 2.78 | −0.80 | −22.3 | ▼ 3 | 15 · 3d | 14% | Biotechnology & Health Technologies 0 · Inception |
| Gambia | Africa | High 0.66 | 3.32 | 2.52 | −0.80 | −24.2 | ▼ 1 | 19 · 4d | 15% | Biotechnology & Health Technologies 0 · Inception |
| Equatorial Guinea | Africa | High 0.65 | 2.80 | 2.00 | −0.80 | −28.7 | ▲ 1 | 23 · 3d | 12% | Biotechnology & Health Technologies 0 · Inception |
| Hungary | Europe | High 0.88 | 10.51 | 9.73 | −0.78 | −7.4 | 0 | 29 · 3d | 43% | Information Environment & Strategic Communication 7.8 · Foundational |
| Croatia | Europe | High 0.81 | 9.53 | 8.75 | −0.78 | −8.2 | ▼ 2 | 24 · 2d | 38% | Biotechnology & Health Technologies 4.1 · Nascent |
| Uruguay | Latin America and Caribbean | High 0.78 | 8.54 | 7.77 | −0.78 | −9.1 | 0 | 21 · 3d | 36% | Biotechnology & Health Technologies 3.5 · Nascent |
| Dominican Republic | Latin America and Caribbean | High 0.70 | 6.82 | 6.04 | −0.78 | −11.4 | ▼ 2 | 20 · 3d | 27% | Biotechnology & Health Technologies 0.9 · Inception |
| Armenia | Russia and Eurasia | High 0.69 | 6.65 | 5.87 | −0.78 | −11.7 | 0 | 16 · 3d | 27% | Biotechnology & Health Technologies 1.3 · Inception |
| Jamaica | Latin America and Caribbean | High 0.70 | 6.24 | 5.47 | −0.78 | −12.4 | ▲ 1 | 25 · 3d | 26% | Biotechnology & Health Technologies 1.1 · Inception |
| Honduras | Latin America and Caribbean | High 0.64 | 5.05 | 4.27 | −0.78 | −15.5 | 0 | 27 · 5d | 20% | Biotechnology & Health Technologies 0.3 · Inception |
| Saint Kitts & Nevis | Latin America and Caribbean | High 0.67 | 3.83 | 3.06 | −0.78 | −20.3 | ▼ 2 | 19 · 2d | 17% | Biotechnology & Health Technologies 0 · Inception |
| Serbia | Europe | High 0.78 | 8.97 | 8.19 | −0.77 | −8.6 | ▼ 1 | 26 · 3d | 36% | Biotechnology & Health Technologies 5.3 · Nascent |
| Tunisia | Africa | High 0.72 | 7.71 | 6.94 | −0.77 | −10.0 | 0 | 18 · 2d | 31% | Biotechnology & Health Technologies 4.5 · Nascent |
| Panama | Latin America and Caribbean | High 0.72 | 7.17 | 6.40 | −0.77 | −10.8 | 0 | 14 · 3d | 30% | Biotechnology & Health Technologies 1.7 · Inception |
| Trinidad & Tobago | Latin America and Caribbean | High 0.69 | 6.69 | 5.92 | −0.77 | −11.6 | 0 | 28 · 2d | 27% | Biotechnology & Health Technologies 0.7 · Inception |
| Bolivia | Latin America and Caribbean | High 0.65 | 5.11 | 4.34 | −0.77 | −15.0 | ▲ 2 | 20 | 21% | Biotechnology & Health Technologies 0 · Inception |
| Maldives | South Asia | High 0.69 | 4.62 | 3.85 | −0.77 | −16.7 | ▲ 1 | 22 · 1d | 22% | Biotechnology & Health Technologies 0 · Inception |
| Laos | Indo-Pacific | High 0.63 | 3.70 | 2.93 | −0.77 | −20.9 | ▼ 2 | 18 · 2d | 15% | Biotechnology & Health Technologies 0 · Inception |
| Slovakia | Europe | High 0.81 | 10.10 | 9.34 | −0.76 | −7.5 | ▼ 1 | 27 · 4d | 40% | Biotechnology & Health Technologies 5.1 · Nascent |
| Costa Rica | Latin America and Caribbean | High 0.75 | 7.76 | 7.00 | −0.76 | −9.8 | 0 | 26 · 4d | 35% | Biotechnology & Health Technologies 2.7 · Inception |
| Botswana | Africa | High 0.68 | 6.08 | 5.32 | −0.76 | −12.5 | ▼ 1 | 19 · 3d | 26% | Biotechnology & Health Technologies 0.3 · Inception |
| Saint Lucia | Latin America and Caribbean | High 0.66 | 3.85 | 3.10 | −0.76 | −19.6 | 0 | 21 · 2d | 17% | Biotechnology & Health Technologies 0 · Inception |
| Lesotho | Africa | High 0.63 | 3.43 | 2.67 | −0.76 | −22.1 | ▼ 1 | 19 · 1d | 14% | Biotechnology & Health Technologies 0 · Inception |
| Lithuania | Europe | High 0.87 | 10.75 | 10.00 | −0.75 | −7.0 | 0 | 22 · 2d | 44% | Biotechnology & Health Technologies 6.5 · Foundational |
| Slovenia | Europe | High 0.85 | 10.48 | 9.73 | −0.75 | −7.2 | 0 | 16 · 2d | 43% | Information Environment & Strategic Communication 6.5 · Foundational |
| Bahrain | Gulf and Middle East | High 0.68 | 7.32 | 6.57 | −0.75 | −10.2 | ▼ 2 | 22 | 29% | Biotechnology & Health Technologies 0.5 · Inception |
| Ecuador | Latin America and Caribbean | High 0.67 | 6.76 | 6.01 | −0.75 | −11.1 | ▼ 1 | 25 · 2d | 27% | Biotechnology & Health Technologies 2.3 · Inception |
| Namibia | Africa | High 0.66 | 5.95 | 5.20 | −0.75 | −12.6 | ▼ 5 | 17 · 2d | 25% | Biotechnology & Health Technologies 0.5 · Inception |
| Cambodia | Indo-Pacific | High 0.62 | 4.93 | 4.18 | −0.75 | −15.1 | 0 | 20 · 2d | 19% | Biotechnology & Health Technologies 0 · Inception |
| Iceland | Europe | High 0.84 | 9.63 | 8.89 | −0.74 | −7.7 | 0 | 27 · 2d | 43% | Biotechnology & Health Technologies 4.6 · Nascent |
| Angola | Africa | Medium 0.59 | 4.60 | 3.86 | −0.74 | −16.1 | ▲ 3 | 15 · 1d | 17% | Biotechnology & Health Technologies 0 · Inception |
| Antigua & Barbuda | Latin America and Caribbean | High 0.65 | 4.36 | 3.62 | −0.74 | −16.9 | ▲ 1 | 15 · 2d | 19% | Biotechnology & Health Technologies 0 · Inception |
| Belize | Latin America and Caribbean | High 0.64 | 4.03 | 3.29 | −0.74 | −18.4 | ▲ 1 | 16 · 1d | 18% | Biotechnology & Health Technologies 0 · Inception |
| Holy See | Europe | High 1.00 | 1.85 | 1.11 | −0.74 | −39.9 | 0 | 9 · 1d | 12% | Biotechnology & Health Technologies 0 · Inception |
| Somalia | Africa | Medium 0.58 | 1.62 | 0.88 | −0.74 | −45.7 | ▼ 1 | 2 | 6% | Biotechnology & Health Technologies 0 · Inception |
| Guyana | Latin America and Caribbean | High 0.62 | 4.53 | 3.80 | −0.73 | −16.2 | ▲ 3 | 17 · 1d | 19% | Biotechnology & Health Technologies 0 · Inception |
| DR Congo | Africa | Medium 0.57 | 2.87 | 2.14 | −0.73 | −25.4 | 0 | 22 · 5d | 11% | Biotechnology & Health Technologies 0.1 · Inception |
| Estonia | Europe | High 0.88 | 11.49 | 10.76 | −0.72 | −6.3 | ▼ 1 | 14 · 2d | 47% | Biotechnology & Health Technologies 6 · Nascent |
| Malaysia | Indo-Pacific | High 0.81 | 11.48 | 10.77 | −0.72 | −6.2 | ▲ 1 | 23 · 2d | 43% | Biotechnology & Health Technologies 8 · Foundational |
| Myanmar | Indo-Pacific | Medium 0.55 | 3.89 | 3.17 | −0.72 | −18.4 | 0 | 19 · 3d | 14% | Biotechnology & Health Technologies 0.8 · Inception |
| Czechia | Europe | High 0.86 | 11.51 | 10.80 | −0.71 | −6.2 | 0 | 19 · 4d | 47% | Biotechnology & Health Technologies 8.4 · Foundational |
| Morocco | Africa | High 0.72 | 9.36 | 8.65 | −0.71 | −7.6 | 0 | 15 · 3d | 36% | Biotechnology & Health Technologies 5 · Nascent |
| Peru | Latin America and Caribbean | High 0.68 | 8.61 | 7.90 | −0.71 | −8.2 | 0 | 24 · 2d | 33% | Biotechnology & Health Technologies 4.2 · Nascent |
| Mauritius | Africa | High 0.69 | 8.08 | 7.37 | −0.71 | −8.8 | ▼ 1 | 19 · 2d | 34% | Biotechnology & Health Technologies 2.4 · Inception |
| Algeria | Africa | High 0.64 | 6.96 | 6.25 | −0.71 | −10.2 | 0 | 22 · 2d | 28% | Biotechnology & Health Technologies 3 · Nascent |
| Bhutan | South Asia | High 0.62 | 3.93 | 3.22 | −0.71 | −18.0 | 0 | 15 · 2d | 19% | Biotechnology & Health Technologies 0 · Inception |
| Tonga | Indo-Pacific | High 0.60 | 3.21 | 2.50 | −0.71 | −22.1 | ▼ 1 | 18 · 3d | 15% | Biotechnology & Health Technologies 0 · Inception |
| Romania | Europe | High 0.74 | 10.16 | 9.46 | −0.70 | −6.9 | 0 | 17 · 1d | 39% | Biotechnology & Health Technologies 7 · Foundational |
| Georgia | Russia and Eurasia | High 0.66 | 7.55 | 6.84 | −0.70 | −9.3 | 0 | 24 · 2d | 31% | Biotechnology & Health Technologies 2 · Inception |
| Micronesia | Indo-Pacific | Medium 0.58 | 2.33 | 1.63 | −0.70 | −30.0 | ▼ 2 | 12 · 1d | 12% | Biotechnology & Health Technologies 0 · Inception |
| South Sudan | Africa | Medium 0.56 | 1.38 | 0.67 | −0.70 | −51.1 | 0 | 2 | 6% | Biotechnology & Health Technologies 0 · Inception |
| Thailand | Indo-Pacific | High 0.78 | 10.70 | 10.00 | −0.69 | −6.5 | ▲ 2 | 22 · 3d | 42% | Biotechnology & Health Technologies 7.7 · Foundational |
| Chile | Latin America and Caribbean | High 0.77 | 10.61 | 9.92 | −0.69 | −6.5 | ▲ 1 | 13 · 3d | 42% | Biotechnology & Health Technologies 5.3 · Nascent |
| Argentina | Latin America and Caribbean | High 0.72 | 9.25 | 8.56 | −0.69 | −7.4 | ▼ 1 | 18 · 3d | 38% | Information Environment & Strategic Communication 6.7 · Foundational |
| Kuwait | Gulf and Middle East | High 0.64 | 7.51 | 6.82 | −0.69 | −9.2 | 0 | 21 · 2d | 31% | Biotechnology & Health Technologies 1.7 · Inception |
| Cuba | Latin America and Caribbean | High 0.69 | 5.95 | 5.26 | −0.69 | −11.6 | ▼ 1 | 17 · 2d | 36% | Fiscal Capacity & Public Finance 3.2 · Nascent |
| Guinea | Africa | Medium 0.55 | 3.15 | 2.45 | −0.69 | −22.0 | ▲ 1 | 16 · 5d | 13% | Biotechnology & Health Technologies 0 · Inception |
| Liberia | Africa | Medium 0.56 | 2.93 | 2.25 | −0.69 | −23.4 | ▼ 1 | 16 · 5d | 13% | Biotechnology & Health Technologies 0 · Inception |
| Vietnam | Indo-Pacific | High 0.71 | 9.68 | 8.99 | −0.68 | −7.1 | 0 | 21 · 2d | 38% | Biotechnology & Health Technologies 6.9 · Foundational |
| Colombia | Latin America and Caribbean | High 0.69 | 9.11 | 8.43 | −0.68 | −7.5 | ▼ 1 | 20 · 3d | 36% | Biotechnology & Health Technologies 4.9 · Nascent |
| Jordan | Gulf and Middle East | High 0.64 | 7.50 | 6.81 | −0.68 | −9.1 | 0 | 17 | 31% | Biotechnology & Health Technologies 3.1 · Nascent |
| Ghana | Africa | High 0.60 | 6.98 | 6.30 | −0.68 | −9.7 | 0 | 14 · 1d | 27% | Biotechnology & Health Technologies 3.5 · Nascent |
| Zambia | Africa | Medium 0.56 | 4.93 | 4.25 | −0.68 | −13.7 | ▲ 2 | 19 | 19% | Biotechnology & Health Technologies 1.1 · Inception |
| Mozambique | Africa | Medium 0.55 | 4.12 | 3.44 | −0.68 | −16.6 | ▼ 1 | 14 | 17% | Biotechnology & Health Technologies 0.8 · Inception |
| São Tomé & Príncipe | Africa | Medium 0.57 | 2.85 | 2.17 | −0.68 | −23.8 | ▲ 2 | 21 · 1d | 13% | Biotechnology & Health Technologies 0 · Inception |
| Haiti | Latin America and Caribbean | Medium 0.53 | 2.03 | 1.34 | −0.68 | −33.8 | 0 | 8 | 8% | Biotechnology & Health Technologies 0 · Inception |
| Belgium | Europe | High 0.95 | 13.46 | 12.79 | −0.67 | −5.0 | 0 | 26 · 4d | 55% | Information Environment & Strategic Communication 9.7 · Transitional |
| Portugal | Europe | High 0.81 | 11.68 | 11.01 | −0.67 | −5.8 | 0 | 16 · 4d | 47% | Biotechnology & Health Technologies 8.3 · Foundational |
| Oman | Gulf and Middle East | High 0.64 | 8.03 | 7.36 | −0.67 | −8.3 | ▼ 1 | 22 · 1d | 32% | Biotechnology & Health Technologies 1.5 · Inception |
| Liechtenstein | Europe | High 0.65 | 7.22 | 6.55 | −0.67 | −9.3 | ▼ 1 | 16 · 5d | 29% | Biotechnology & Health Technologies 0 · Inception |
| Guatemala | Latin America and Caribbean | Medium 0.56 | 5.67 | 4.99 | −0.67 | −11.9 | ▲ 4 | 15 · 2d | 22% | Biotechnology & Health Technologies 0.9 · Inception |
| Ireland | Europe | High 0.84 | 12.08 | 11.42 | −0.66 | −5.5 | 0 | 19 · 2d | 49% | Biotechnology & Health Technologies 9.7 · Transitional |
| Barbados | Latin America and Caribbean | High 0.61 | 5.56 | 4.90 | −0.66 | −11.9 | ▲ 2 | 13 · 3d | 24% | Biotechnology & Health Technologies 0 · Inception |
| Madagascar | Africa | Medium 0.52 | 3.90 | 3.24 | −0.66 | −17.0 | ▲ 4 | 5 · 1d | 16% | Biotechnology & Health Technologies 0.7 · Inception |
| Timor-Leste | Indo-Pacific | Medium 0.55 | 2.98 | 2.33 | −0.66 | −22.0 | ▲ 2 | 17 · 2d | 13% | Biotechnology & Health Technologies 0 · Inception |
| Solomon Islands | Indo-Pacific | Medium 0.55 | 2.91 | 2.25 | −0.66 | −22.6 | ▲ 2 | 13 · 2d | 14% | Biotechnology & Health Technologies 0 · Inception |
| Mexico | Latin America and Caribbean | High 0.73 | 10.85 | 10.20 | −0.65 | −6.0 | 0 | 21 · 2d | 42% | Labour & Employment 8.5 · Foundational |
| Palestine | Gulf and Middle East | Medium 0.52 | 3.72 | 3.06 | −0.65 | −17.6 | ▲ 4 | 10 · 2d | 17% | Biotechnology & Health Technologies 0.1 · Inception |
| Eswatini | Africa | Medium 0.54 | 3.71 | 3.06 | −0.65 | −17.5 | ▲ 4 | 11 | 16% | Biotechnology & Health Technologies 0 · Inception |
| Samoa | Indo-Pacific | Medium 0.56 | 3.48 | 2.83 | −0.65 | −18.6 | 0 | 18 · 3d | 16% | Biotechnology & Health Technologies 0 · Inception |
| Poland | Europe | High 0.79 | 12.39 | 11.76 | −0.64 | −5.1 | ▼ 1 | 16 · 2d | 48% | Biotechnology & Health Technologies 10 · Transitional |
| Cameroon | Africa | Medium 0.51 | 4.39 | 3.75 | −0.64 | −14.7 | ▲ 1 | 12 · 1d | 17% | Biotechnology & Health Technologies 0.9 · Inception |
| Mali | Africa | Medium 0.51 | 3.41 | 2.77 | −0.64 | −18.7 | ▲ 1 | 18 · 3d | 14% | Biotechnology & Health Technologies 0.3 · Inception |
| Eritrea | Africa | Medium 0.50 | 2.01 | 1.37 | −0.64 | −31.8 | ▲ 2 | 11 · 1d | 9% | Biotechnology & Health Technologies 0 · Inception |
| Central African Rep. | Africa | Medium 0.50 | 1.66 | 1.03 | −0.64 | −38.3 | 0 | 7 | 7% | Biotechnology & Health Technologies 0 · Inception |
| Azerbaijan | Russia and Eurasia | Medium 0.57 | 6.79 | 6.16 | −0.63 | −9.3 | ▲ 2 | 13 · 1d | 28% | Biotechnology & Health Technologies 1.2 · Inception |
| Senegal | Africa | Medium 0.55 | 6.42 | 5.79 | −0.63 | −9.8 | ▲ 1 | 25 · 2d | 26% | Biotechnology & Health Technologies 3.4 · Nascent |
| Moldova | Russia and Eurasia | Medium 0.57 | 6.34 | 5.71 | −0.63 | −10.0 | ▲ 1 | 20 · 4d | 28% | Biotechnology & Health Technologies 1.8 · Inception |
| Togo | Africa | Medium 0.51 | 4.05 | 3.43 | −0.63 | −15.4 | 0 | 14 | 16% | Biotechnology & Health Technologies 0 · Inception |
| Ukraine | Russia and Eurasia | High 0.64 | 9.40 | 8.79 | −0.62 | −6.6 | 0 | 23 · 1d | 38% | Biotechnology & Health Technologies 5.8 · Nascent |
| Nigeria | Africa | Medium 0.55 | 7.43 | 6.81 | −0.62 | −8.3 | 0 | 17 · 3d | 28% | Population Health 3.1 · Nascent |
| Iraq | Gulf and Middle East | Medium 0.50 | 4.69 | 4.07 | −0.62 | −13.3 | ▲ 3 | 17 | 19% | Biotechnology & Health Technologies 1 · Inception |
| Taiwan | Indo-Pacific | High 0.86 | 14.03 | 13.42 | −0.61 | −4.3 | 0 | 22 · 4d | 55% | Biotechnology & Health Technologies 12 · Established |
| Côte d'Ivoire | Africa | Medium 0.50 | 5.42 | 4.81 | −0.61 | −11.2 | ▲ 2 | 15 · 1d | 21% | Biotechnology & Health Technologies 1 · Inception |
| Benin | Africa | Medium 0.50 | 4.09 | 3.48 | −0.61 | −14.9 | ▲ 1 | 12 · 1d | 17% | Biotechnology & Health Technologies 0 · Inception |
| Vanuatu | Indo-Pacific | Medium 0.51 | 2.93 | 2.31 | −0.61 | −20.9 | ▲ 3 | 15 | 14% | Biotechnology & Health Technologies 0 · Inception |
| South Africa | Africa | High 0.67 | 10.77 | 10.17 | −0.60 | −5.6 | ▲ 1 | 16 | 42% | Population Health 8.2 · Foundational |
| Sudan | Africa | Medium 0.44 | 2.61 | 2.01 | −0.60 | −23.1 | ▲ 3 | 14 · 1d | 9% | Biotechnology & Health Technologies 0 · Inception |
| Guinea-Bissau | Africa | Medium 0.48 | 2.07 | 1.47 | −0.60 | −29.0 | ▲ 2 | 16 · 1d | 9% | Biotechnology & Health Technologies 0 · Inception |
| Denmark | Europe | High 0.90 | 13.94 | 13.36 | −0.59 | −4.2 | 0 | 14 · 2d | 58% | Information Environment & Strategic Communication 10.9 · Transitional |
| Austria | Europe | High 0.81 | 12.81 | 12.21 | −0.59 | −4.6 | 0 | 22 · 2d | 53% | Information Environment & Strategic Communication 9.2 · Transitional |
| Bangladesh | South Asia | Medium 0.53 | 6.73 | 6.14 | −0.59 | −8.7 | ▲ 3 | 17 | 28% | Biotechnology & Health Technologies 4.5 · Nascent |
| Nepal | South Asia | Medium 0.49 | 4.96 | 4.37 | −0.59 | −12.0 | ▲ 6 | 12 · 2d | 21% | Biotechnology & Health Technologies 0.8 · Inception |
| Sierra Leone | Africa | Medium 0.48 | 3.59 | 3.00 | −0.59 | −16.4 | ▲ 2 | 16 · 3d | 15% | Biotechnology & Health Technologies 0 · Inception |
| Burkina Faso | Africa | Medium 0.47 | 3.47 | 2.88 | −0.59 | −16.9 | ▲ 2 | 17 · 1d | 15% | Biotechnology & Health Technologies 0.4 · Inception |
| Burundi | Africa | Medium 0.48 | 2.48 | 1.89 | −0.59 | −23.8 | 0 | 15 · 3d | 10% | Biotechnology & Health Technologies 0 · Inception |
| Comoros | Africa | Medium 0.48 | 2.29 | 1.69 | −0.59 | −25.9 | ▲ 1 | 12 · 2d | 10% | Biotechnology & Health Technologies 0 · Inception |
| Netherlands | Europe | High 0.94 | 15.50 | 14.92 | −0.58 | −3.7 | 0 | 9 · 1d | 61% | Information Environment & Strategic Communication 12.6 · Established |
| Spain | Europe | High 0.80 | 13.78 | 13.21 | −0.58 | −4.2 | 0 | 11 | 54% | Labour & Employment 12.4 · Established |
| Italy | Europe | High 0.78 | 13.72 | 13.14 | −0.58 | −4.3 | 0 | 16 · 1d | 52% | Labour & Employment 10.9 · Transitional |
| Brazil | Latin America and Caribbean | High 0.70 | 11.69 | 11.11 | −0.58 | −5.0 | 0 | 19 · 2d | 46% | Labour & Employment 9.9 · Transitional |
| Philippines | Indo-Pacific | Medium 0.57 | 8.83 | 8.25 | −0.58 | −6.6 | ▲ 3 | 19 · 3d | 35% | Biotechnology & Health Technologies 4.9 · Nascent |
| Kyrgyzstan | Russia and Eurasia | Medium 0.48 | 4.77 | 4.19 | −0.58 | −12.2 | ▲ 2 | 14 | 20% | Biotechnology & Health Technologies 0.4 · Inception |
| Zimbabwe | Africa | Medium 0.46 | 4.34 | 3.75 | −0.58 | −13.5 | ▲ 5 | 12 · 2d | 17% | Biotechnology & Health Technologies 1.5 · Inception |
| Papua New Guinea | Indo-Pacific | Medium 0.45 | 3.80 | 3.23 | −0.58 | −15.1 | ▲ 7 | 13 | 14% | Biotechnology & Health Technologies 0 · Inception |
| Syria | Gulf and Middle East | Medium 0.43 | 2.22 | 1.64 | −0.58 | −26.1 | ▲ 2 | 14 · 1d | 8% | Biotechnology & Health Technologies 0 · Inception |
| Singapore | Indo-Pacific | High 0.94 | 15.20 | 14.62 | −0.57 | −3.8 | 0 | 14 · 4d | 60% | Information Environment & Strategic Communication 13.2 · Established |
| Indonesia | Indo-Pacific | High 0.60 | 9.97 | 9.40 | −0.57 | −5.7 | ▲ 1 | 16 · 1d | 39% | Biotechnology & Health Technologies 7.5 · Foundational |
| Finland | Europe | High 0.85 | 14.52 | 13.96 | −0.56 | −3.8 | ▼ 1 | 18 · 2d | 58% | Information Environment & Strategic Communication 11.6 · Transitional |
| Uzbekistan | Russia and Eurasia | Medium 0.48 | 5.92 | 5.36 | −0.56 | −9.5 | ▲ 4 | 19 · 2d | 24% | Biotechnology & Health Technologies 2.7 · Inception |
| Sweden | Europe | High 0.89 | 15.30 | 14.76 | −0.55 | −3.6 | 0 | 15 | 60% | Information Environment & Strategic Communication 12.9 · Established |
| New Zealand | Indo-Pacific | High 0.76 | 12.83 | 12.28 | −0.55 | −4.3 | 0 | 23 · 1d | 53% | Biotechnology & Health Technologies 9.1 · Transitional |
| Qatar | Gulf and Middle East | Medium 0.60 | 9.39 | 8.84 | −0.55 | −5.8 | ▲ 2 | 11 · 1d | 41% | Biotechnology & Health Technologies 3.3 · Nascent |
| Iran | Gulf and Middle East | Medium 0.54 | 8.17 | 7.62 | −0.55 | −6.7 | 0 | 14 · 1d | 35% | Fiscal Capacity & Public Finance 5.4 · Nascent |
| Kazakhstan | Russia and Eurasia | Medium 0.53 | 8.14 | 7.60 | −0.55 | −6.7 | 0 | 23 · 2d | 33% | Biotechnology & Health Technologies 4.7 · Nascent |
| Sri Lanka | South Asia | Medium 0.50 | 7.25 | 6.70 | −0.55 | −7.6 | 0 | 20 · 2d | 29% | Biotechnology & Health Technologies 3.1 · Nascent |
| Malawi | Africa | Medium 0.44 | 3.76 | 3.22 | −0.55 | −14.6 | ▲ 6 | 12 · 1d | 17% | Biotechnology & Health Technologies 1.1 · Inception |
| Turkmenistan | Russia and Eurasia | Medium 0.44 | 3.55 | 3.00 | −0.55 | −15.6 | ▲ 3 | 15 · 5d | 14% | Biotechnology & Health Technologies 0 · Inception |
| Norway | Europe | High 0.81 | 14.62 | 14.08 | −0.54 | −3.7 | 0 | 15 · 1d | 57% | Biotechnology & Health Technologies 11 · Transitional |
| United Arab Emirates | Gulf and Middle East | High 0.64 | 11.94 | 11.40 | −0.54 | −4.5 | 0 | 22 · 2d | 46% | Biotechnology & Health Technologies 7 · Foundational |
| Pakistan | South Asia | Medium 0.49 | 7.96 | 7.42 | −0.54 | −6.7 | ▲ 2 | 18 · 2d | 29% | Population Health 4.3 · Nascent |
| Tanzania | Africa | Medium 0.46 | 5.82 | 5.28 | −0.54 | −9.3 | ▲ 3 | 14 · 2d | 23% | Biotechnology & Health Technologies 2.3 · Inception |
| Afghanistan | South Asia | Medium 0.43 | 1.46 | 0.92 | −0.54 | −36.9 | ▲ 1 | 8 | 8% | Biotechnology & Health Technologies 0 · Inception |
| Switzerland | Europe | High 0.86 | 14.73 | 14.20 | −0.53 | −3.6 | 0 | 12 | 60% | Information Environment & Strategic Communication 11.6 · Transitional |
| Chad | Africa | Medium 0.41 | 2.26 | 1.74 | −0.52 | −23.0 | ▲ 3 | 14 · 2d | 9% | Biotechnology & Health Technologies 0 · Inception |
| South Korea | Indo-Pacific | High 0.83 | 16.00 | 15.49 | −0.51 | −3.2 | 0 | 9 · 1d | 61% | Labour & Employment 14 · Established |
| Canada | North America | High 0.80 | 15.06 | 14.55 | −0.51 | −3.4 | 0 | 11 · 2d | 59% | Information Environment & Strategic Communication 12.7 · Established |
| Yemen | Gulf and Middle East | Medium 0.38 | 1.62 | 1.12 | −0.51 | −31.1 | ▲ 3 | 5 | 6% | Biotechnology & Health Technologies 0 · Inception |
| Türkiye | Gulf and Middle East | Medium 0.58 | 12.18 | 11.69 | −0.49 | −4.0 | 0 | 18 · 2d | 46% | Biotechnology & Health Technologies 9.5 · Transitional |
| Rwanda | Africa | Medium 0.44 | 5.95 | 5.46 | −0.49 | −8.3 | ▲ 4 | 11 · 1d | 28% | Biotechnology & Health Technologies 3.2 · Nascent |
| Uganda | Africa | Medium 0.41 | 5.53 | 5.04 | −0.49 | −8.9 | ▲ 8 | 14 · 3d | 23% | Biotechnology & Health Technologies 3 · Nascent |
| Ethiopia | Africa | Medium 0.40 | 5.70 | 5.21 | −0.48 | −8.4 | ▲ 5 | 21 · 3d | 23% | Biotechnology & Health Technologies 2.7 · Inception |
| Russia | Russia and Eurasia | Medium 0.58 | 12.30 | 11.83 | −0.47 | −3.8 | ▲ 1 | 10 | 48% | Population Health 9.1 · Transitional |
| Saudi Arabia | Gulf and Middle East | Medium 0.54 | 11.19 | 10.72 | −0.47 | −4.2 | 0 | 17 · 3d | 44% | Biotechnology & Health Technologies 7.1 · Foundational |
| Kenya | Africa | Medium 0.42 | 7.18 | 6.71 | −0.47 | −6.5 | ▲ 3 | 12 | 28% | Biotechnology & Health Technologies 4.3 · Nascent |
| Niger | Africa | Medium 0.36 | 3.07 | 2.60 | −0.47 | −15.3 | ▲ 5 | 11 · 3d | 13% | Biotechnology & Health Technologies 0.3 · Inception |
| France | Europe | High 0.81 | 16.64 | 16.18 | −0.46 | −2.8 | 0 | 5 | 63% | Labour & Employment 14.1 · Established |
| Germany | Europe | High 0.82 | 16.36 | 15.90 | −0.46 | −2.8 | 0 | 10 | 64% | Foundational Education 14.6 · Established |
| Japan | Indo-Pacific | High 0.81 | 16.26 | 15.80 | −0.46 | −2.8 | 0 | 11 | 63% | Information Environment & Strategic Communication 14.8 · Established |
| Australia | Indo-Pacific | High 0.75 | 14.95 | 14.48 | −0.46 | −3.1 | 0 | 10 · 1d | 60% | Information Environment & Strategic Communication 13.4 · Established |
| Tajikistan | Russia and Eurasia | Medium 0.36 | 4.01 | 3.56 | −0.45 | −11.2 | ▲ 8 | 12 | 17% | Biotechnology & Health Technologies 0.3 · Inception |
| Israel | Gulf and Middle East | High 0.64 | 14.46 | 14.02 | −0.44 | −3.0 | ▲ 1 | 14 · 1d | 56% | Trade Facilitation & Logistics 12.7 · Established |
| India | South Asia | Medium 0.53 | 12.61 | 12.17 | −0.44 | −3.5 | 0 | 15 · 1d | 46% | Labour & Employment 7.4 · Foundational |
| United Kingdom | Europe | High 0.78 | 16.45 | 16.02 | −0.43 | −2.6 | 0 | 11 | 64% | Labour & Employment 14.2 · Established |
| China | China | High 0.65 | 15.64 | 15.22 | −0.42 | −2.7 | 0 | 10 · 1d | 58% | Population Health 10.9 · Transitional |
| Egypt | Gulf and Middle East | Medium 0.40 | 8.98 | 8.57 | −0.40 | −4.5 | ▲ 2 | 14 · 1d | 35% | Labour & Employment 6.5 · Foundational |
| United States | North America | High 0.71 | 18.03 | 17.64 | −0.38 | −2.1 | 0 | 11 · 4d | 65% | Population Health 13.3 · Established |
Settings of this run
- Load
- 11 capability groups singled out, 73 loaded in all, of 73. A band on the capability scale is three points wide, so a High load moves a fully exposed, unprotected capability down one band. A capability group that the scenario does not single out takes its domain's load one level lower.
- Singled out
- Biotechnology & Health TechnologiesHighSocial InfrastructureMediumFoundational EducationHighPopulation HealthHighHealth System CapabilityHighInformation Environment & Strategic CommunicationHighGovernment Effectiveness & Public AdministrationHighNational Resilience & Crisis ManagementHighFiscal Capacity & Public FinanceHighLabour & EmploymentHighTrade Facilitation & LogisticsHigh
- Buffers
- Health System CapabilityBiotechnology & Health TechnologiesNational Resilience & Crisis ManagementInformation Environment & Strategic CommunicationFiscal Capacity & Public Finance
Absorption is the nation's mean score on the scenario's buffer capabilities as a share of the top of the scale, times 0.75: a nation at the frontier on every buffer absorbs three quarters of the shock.
- Exposure
- regional exposure (30%); urban share of population (30%); share of population aged 65 and over (ranked) (20%); trade in goods and services relative to gdp (ranked) (20%). Exposure is set nation by nation: a weighted blend of indicators from the 2025 World Factbook and the scenario's regional exposure. Where a nation does not report an indicator, its weight passes to the others.
- Likelihood
- 4 per cent over three years and 15 per cent over ten, as used in the vulnerability index.